BARCELONA, Spain

Meritxell Gironella Cos

This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignees: Consorcio Centro De Investigacion Biomedica En Red, Hospital Clinic De Barcelona, Institut D'investigacions Biomediques August Pi I Sunyer (Idibaps). Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Meritxell Gironella Cos. Retrieved from https://idiyas.com/inventor/meritxell-gironella-cos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Meritxell Gironella Cos: Innovator in Colorectal Cancer Diagnostics

Introduction

Meritxell Gironella Cos is a prominent inventor based in Barcelona, Spain. She is currently associated with Advanced Marker Discovery, S.L. Despite having no granted patents to her name, her contributions to the field of colorectal cancer diagnostics are noteworthy.

Latest Patent Applications

Meritxell has been involved in several significant patent applications. One of her latest applications is titled "Non-invasive method for the diagnosis or screening of colorectal cancer and/or pre-cancerous stage thereof." This invention refers to an in vitro method aimed at diagnosing colorectal cancer and/or its pre-cancerous stages. Another important application is "In vitro method for identifying colorectal adenomas or colorectal cancer." This method focuses on identifying patients at risk of colorectal cancer and/or colorectal adenomas by measuring the expression profile of specific miRNAs that are up-regulated in affected patients.

Conclusion

Meritxell Gironella Cos is making strides in the field of medical diagnostics, particularly in colorectal cancer. Her innovative approaches have the potential to significantly impact patient care and early detection methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…